Advertisement
U.S. markets closed

Athira Pharma, Inc. (ATHA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.7400+0.1800 (+7.03%)
At close: 04:00PM EDT
2.7400 0.00 (0.00%)
After hours: 07:38PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close2.5600
Open2.5900
Bid2.7200 x 200
Ask2.7700 x 200
Day's Range2.5500 - 2.8250
52 Week Range1.3300 - 4.2980
Volume577,953
Avg. Volume444,503
Market Cap105.015M
Beta (5Y Monthly)2.85
PE Ratio (TTM)N/A
EPS (TTM)-3.0900
Earnings DateMay 09, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.42
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ATHA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Athira Pharma, Inc.
    Daily – Vickers Top Buyers & Sellers for 06/07/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    10 months agoArgus Research
View more